Skip to main content
. 2007 Apr 18;2:9. doi: 10.1186/1750-9378-2-9

Table 1.

Immunization schedule of the study

Groups Adjuvant/Carrier1 Immunogens Amounts Site of injection1 Symbol used in Figure 1
PR75–84 wt IFA VLVGPTPVNI 4 × 50 μg s.c Downward pointing triangle
PR75–84 d.mut IFA VLVGPTPFNV 4 × 50 μg s.c Black filled Diamond
PR75–84 d.mut low2 - VLVGPTPFNV 4 × 5 μg s.c Blue open Diamond
RBC-PR75–84 wt RBC VLVGPTPVNI biotinylated to synergeneic erythrocytes 2 × 5 ng3 + 2 × 12.5 ng4 i.p Square
RBC-PR75–84 d.mut RBC VLVGPTPFNV biotinylated to syngeneic erythrocytes 2 × 5 ng3 + 2 × 12.5 ng4 i.p Triangle
RBCempty RBC Biotinylated syngeneic erythrocytes 3 × 200 μl + 1 × 500 μl blood i.p Circle
Untreated - - - - Cross

1 IFA = Incomplete Freunds adjuvant; RBC = Red blood cell; s.c = subcutaneous; i.p = intraperitoneal

2A parallel study

3 Corresponds to 200 μl blood

4 Corresponds to 500 μl blood